Hamilton Thorne Ltd. (HTL.V)
- GlobeNewswire
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended September 30, 2021
Revenues up 30%; Adjusted EBITDA up 22% for the quarter;Revenues up 33% and Adjusted EBITDA up 67% for the nine-month period BEVERLY, Mass. and TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and operational results for the quarter and nine months ended September 30, 202
- GlobeNewswire
Hamilton Thorne to Present at Stifel and Piper Sandler Conferences
BEVERLY, Mass. and TORONTO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will be presenting at the Stifel 2021 Healthcare Conference and the Piper Sandler 33rd Annual Healthcare Conference. Stifel 2021 Healthcare Conference David Wolf, President and CEO of Hamilton Thorne Ltd., will par
- GlobeNewswire
Hamilton Thorne to Announce Q3 2021 Financial Results and Hold Conference Call on November 22, 2021
BEVERLY, Mass. and TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the quarter and nine months ended September 30, 2021 before market open on Monday November 22, 2021. The press release, with accompanying financial information, will be posted
